A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Clinical trial NCT01050582 · COMPLETED

Trial details

NCT number: NCT01050582
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Bipolar Disorder Autistic Disorder Conduct and Other Disruptive Behavior Disorders

Start date: 2009-10-01
Primary completion: 2011-07-01
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.